HK1007748A1 - Biological materials processes for producing biological materials and for using such materials in therapy - Google Patents

Biological materials processes for producing biological materials and for using such materials in therapy

Info

Publication number
HK1007748A1
HK1007748A1 HK98107034A HK98107034A HK1007748A1 HK 1007748 A1 HK1007748 A1 HK 1007748A1 HK 98107034 A HK98107034 A HK 98107034A HK 98107034 A HK98107034 A HK 98107034A HK 1007748 A1 HK1007748 A1 HK 1007748A1
Authority
HK
Hong Kong
Prior art keywords
materials
inhs
processes
biological materials
therapy
Prior art date
Application number
HK98107034A
Other languages
English (en)
Inventor
Jean-Michel Dayer
Lucien Philippe Seckinger
Jose Gonzalo Mazzei
Reed Alan Shaw
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22218720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1007748(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of HK1007748A1 publication Critical patent/HK1007748A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)
HK98107034A 1987-08-26 1998-06-26 Biological materials processes for producing biological materials and for using such materials in therapy HK1007748A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8963287A 1987-08-26 1987-08-26
PCT/US1988/002819 WO1989001946A1 (fr) 1987-08-26 1988-08-17 Substances biologiques et procedes de production et d'utilisation de ces substances biologiques en therapeutique

Publications (1)

Publication Number Publication Date
HK1007748A1 true HK1007748A1 (en) 1999-04-23

Family

ID=22218720

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98107034A HK1007748A1 (en) 1987-08-26 1998-06-26 Biological materials processes for producing biological materials and for using such materials in therapy

Country Status (20)

Country Link
EP (1) EP0341273B1 (fr)
JP (2) JP3014099B2 (fr)
KR (2) KR0138919B1 (fr)
AT (1) ATE147408T1 (fr)
AU (1) AU633471B2 (fr)
BE (1) BE1002375A3 (fr)
CA (1) CA1341026C (fr)
DE (1) DE3855747T2 (fr)
DK (1) DK175837B1 (fr)
ES (3) ES2015348A6 (fr)
FR (1) FR2621821A1 (fr)
GB (1) GB2220662A (fr)
HK (1) HK1007748A1 (fr)
IL (1) IL87543A0 (fr)
IT (1) IT1226855B (fr)
NL (1) NL8820676A (fr)
NZ (1) NZ225940A (fr)
SE (1) SE8901342D0 (fr)
WO (1) WO1989001946A1 (fr)
ZA (1) ZA886251B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
KR0148009B1 (ko) * 1988-05-27 1998-08-01 그래고리 비. 아보트 인터루킨-1 억제제
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
BR8907457A (pt) * 1988-05-27 1991-04-02 Synergen Inc Inibidores de interleucina-1
CA2068320C (fr) * 1989-11-29 2000-10-17 Robert Hageman Production d'un inhibiteur recombinant de l'interleukine-1 humaine
US5714140A (en) * 1989-12-13 1998-02-03 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting the production of bioactive IL-1 by administering M-CSF
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
WO1991017184A1 (fr) * 1990-04-27 1991-11-14 The Upjohn Company Inhibiteurs ameliores d'interleukine-1
ATE178094T1 (de) * 1990-05-01 1999-04-15 Chiron Corp Interleukin-i antagonist und seine verwendung
NZ310561A (en) * 1995-09-13 1999-07-29 Takeda Chemical Industries Ltd Immunosuppressant of the aromatic variety based upon the quinoline family
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992367A (en) * 1986-05-12 1991-02-12 Hoffmann-La Roche Inc. Enhanced expression of human interleukin-2 in mammalian cells

Also Published As

Publication number Publication date
GB8912533D0 (en) 1989-08-02
SE8901342L (sv) 1989-04-13
JPH02500643A (ja) 1990-03-08
ES2017275A6 (es) 1991-01-16
EP0341273B1 (fr) 1997-01-08
NL8820676A (nl) 1989-07-03
ES2017274A6 (es) 1991-01-16
DK203189A (da) 1989-04-26
ES2015348A6 (es) 1990-08-16
KR0138919B1 (ko) 1998-04-30
AU2427288A (en) 1989-03-31
IT1226855B (it) 1991-02-19
KR0138654B1 (ko) 1998-04-30
JPH10327862A (ja) 1998-12-15
WO1989001946A1 (fr) 1989-03-09
SE8901342D0 (sv) 1989-04-13
BE1002375A3 (fr) 1991-01-22
ZA886251B (en) 1990-04-25
DK175837B1 (da) 2005-03-21
FR2621821A1 (fr) 1989-04-21
DE3855747D1 (de) 1997-02-20
IL87543A0 (en) 1989-01-31
KR890701629A (ko) 1989-12-21
NZ225940A (en) 1992-06-25
EP0341273A1 (fr) 1989-11-15
AU633471B2 (en) 1993-02-04
JP3217752B2 (ja) 2001-10-15
CA1341026C (fr) 2000-06-13
DK203189D0 (da) 1989-04-26
JP3014099B2 (ja) 2000-02-28
EP0341273A4 (en) 1990-09-19
DE3855747T2 (de) 1997-06-12
GB2220662A (en) 1990-01-17
ATE147408T1 (de) 1997-01-15
IT8821743A0 (it) 1988-08-25

Similar Documents

Publication Publication Date Title
DE3587939D1 (de) Tumornekrosefaktor, Verfahren zu seiner Herstellung, denselben enthaltende Zusammensetzungen, dafür kodierende DNS und diese DNS verwendendes Testverfahren.
MY101852A (en) Tumor necrosis factor, methods for its preparation, containing it, dna encoding it and assay method using such dna.
GB9323165D0 (en) Compounds
GB8912533D0 (en) Biological materials,processes for producing biological materials and for using such materials in therapy
DK0398327T4 (da) Tumornekrosefaktor-bindende protein, dets oprensning og antistoffer dertil
HUT43106A (en) Dns sequences koding proteins of flesh-i type inhibitor activity and process for producing these proteins
ATE159032T1 (de) Anti-hiv protein, tap-29, aus trichosanthes, seine kodierende dna und therapeutischen anwendungen

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20080816